Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Ocrelizumab Shows Similar Efficacy to Fingolimod in Phase 3 OPERETTA 2 Trial for Pediatric Relapsing-Remitting MS
2
Eli Lilly’s Anti-Amyloid Therapy Donanemab Gains EU Approval for Alzheimer Disease
3
Phase 3b GAVOTTE Trial Reveals No Added Benefit With Higher-Dose Ocrelizumab in Primary Progressive MS
4
LGMD Awareness Day: A Researcher’s Perspective on Rare Disease Progress and Gaps
5
